These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20975276)

  • 1. Barriers to opioid substitution treatment access, entry and retention: a survey of opioid users, patients in treatment, and treating and non-treating physicians.
    Stöver H
    Eur Addict Res; 2011; 17(1):44-54. PubMed ID: 20975276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural barriers in the context of opiate substitution treatment in Germany--a survey among physicians in primary care.
    Schulte B; Schmidt CS; Kuhnigk O; Schäfer I; Fischer B; Wedemeyer H; Reimer J
    Subst Abuse Treat Prev Policy; 2013 Jul; 8():26. PubMed ID: 23875627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Attitudes and beliefs regarding opioid maintenance treatment in Portugal: a survey to physicians, patients and opioid users].
    Goulão J
    Acta Med Port; 2013; 26(5):537-48. PubMed ID: 24192093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The politics of providing opioid pharmacotherapy.
    Radcliffe P; Parkes T
    Int J Drug Policy; 2013 Nov; 24(6):e6-10. PubMed ID: 24183331
    [No Abstract]   [Full Text] [Related]  

  • 5. Is opioid substitution treatment beneficial if injecting behaviour continues?
    Gjersing L; Bretteville-Jensen AL
    Drug Alcohol Depend; 2013 Nov; 133(1):121-6. PubMed ID: 23773951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
    Treloar C; Newland J; Rance J; Hopwood M
    J Viral Hepat; 2010 Dec; 17(12):839-44. PubMed ID: 20070504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-prescribed use of substitution medication among German drug users--prevalence, motives and availability.
    Schmidt CS; Schulte B; Wickert C; Thane K; Kuhn S; Verthein U; Reimer J
    Int J Drug Policy; 2013 Nov; 24(6):e111-4. PubMed ID: 23726899
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study.
    Degenhardt L; Larney S; Kimber J; Gisev N; Farrell M; Dobbins T; Weatherburn DJ; Gibson A; Mattick R; Butler T; Burns L
    Addiction; 2014 Aug; 109(8):1306-17. PubMed ID: 24612249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing access to opioid maintenance treatment: the role of primary care in France.
    Roux P; Lions C; Carrieri MP
    Int J Drug Policy; 2015 Apr; 26(4):434-5. PubMed ID: 25683137
    [No Abstract]   [Full Text] [Related]  

  • 10. Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness.
    Deering DEA; Sheridan J; Sellman JD; Adamson SJ; Pooley S; Robertson R; Henderson C
    Addict Behav; 2011 Jun; 36(6):636-642. PubMed ID: 21276664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Opioid substitution therapy in France: a physician's overview].
    Michel L
    Ann Pharm Fr; 2009 Sep; 67(5):369-73. PubMed ID: 19695374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists.
    Lawrinson P; Roche A; Terao H; Le PP
    Drug Alcohol Rev; 2008 Jan; 27(1):47-53. PubMed ID: 18034381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to hospice enrollment among lung cancer patients: a survey of family members and physicians.
    Ford DW; Nietert PJ; Zapka J; Zoller JS; Silvestri GA
    Palliat Support Care; 2008 Dec; 6(4):357-62. PubMed ID: 19006590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS.
    Polonsky M; Azbel L; Wickersham JA; Taxman FS; Grishaev E; Dvoryak S; Altice FL
    Drug Alcohol Depend; 2015 Mar; 148():47-55. PubMed ID: 25620732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid dependence - management in general practice.
    Frei M
    Aust Fam Physician; 2010 Aug; 39(8):548-52. PubMed ID: 20877747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    Farnia M; Ebrahimi B; Shams A; Zamani S
    Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States.
    Lister JJ; Weaver A; Ellis JD; Himle JA; Ledgerwood DM
    Am J Drug Alcohol Abuse; 2020 May; 46(3):273-288. PubMed ID: 31809217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to care of patients with chronic hepatitis C virus infection in a university hospital: Is opioid dependence a limiting condition?
    Perut V; Labalette C; Sogni P; Ferrand I; Salmon-Céron D; Vidal-Trecan G
    Drug Alcohol Depend; 2009 Sep; 104(1-2):78-83. PubMed ID: 19464124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinic-based treatment for opioid dependence: a qualitative inquiry.
    McMurphy S; Shea J; Switzer J; Turner BJ
    Am J Health Behav; 2006; 30(5):544-54. PubMed ID: 16893317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention of service users on opioid substitution therapy in the City of Tshwane, South Africa.
    Goeieman DS; Nonyane DS; Nzaumvila DK; Anse van Rensburg MNS
    Afr J Prim Health Care Fam Med; 2023 Jan; 15(1):e1-e10. PubMed ID: 36744456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.